Skip to content

The study about survey and intervention of primary hospitals' diagnosis and treatment in Meniere's disease

The study about survey and intervention of primary hospitals' diagnosis and treatment in Meniere's disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-HOC-17013102
Enrollment
Unknown
Registered
2017-10-25
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniere's disease

Interventions

Intervention group(doctor):Medical training

Sponsors

Third People's Hospital of Huzhou, Zhejiang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Episodes of paroxysmal vertigo 2 or more times, lasting 20 min to 2 hours each time. Dysfunction of autonomic nervous system and balance disorders. Unconscious loss; 2. The most frequent hearing loss is low frequency hearing loss, and the hearing loss is gradually aggravated with the progression of the disease. At least 1 pure tone audiometry is sensorineural hearing loss, and the phenomenon of auditory recruitment can occur; 3. Associated with tinnitus and (or) ear fullness; 4. Exclusion of other diseases such benign paroxysmal positional vertigo, labyrinthitis and vestibular neuronitis, drug poisoning, sudden deafness, vertigo, vertebrobasilar insufficiency and intracranial lesions.;Inclusion criteria: 1. Episodes of paroxysmal vertigo 2 or more times, lasting 20 min to 2 hours each time. Dysfunction of autonomic nervous system and balance disorders. Unconscious loss; 2. The most frequent hearing loss is low frequency hearing loss, and the hearing loss is gradually aggravated with the progression of the disease. At least 1 pure tone audiometry is sensorineural hearing loss, and the phenomenon of auditory recruitment can occur; 3. Associated with tinnitus and (or) ear fullness; 4. Exclusion of other diseases such benign paroxysmal positional vertigo, labyrinthitis and vestibular neuronitis, drug poisoning, sudden deafness, vertigo, vertebrobasilar insufficiency and intracranial lesions.;Inclusion criteria: 1. Episodes of paroxysmal vertigo 2 or more times, lasting 20 min to 2 hours each time. Dysfunction of autonomic nervous system and balance disorders. Unconscious loss; 2. The most frequent hearing loss is low frequency hearing loss, and the hearing loss is gradually aggravated with the progression of the disease. At least 1 pure tone audiometry is sensorineural hearing loss, and the phenomenon of auditory recruitment can occur; 3. Associated with tinnitus and (or) ear fullness; 4. Exclusion of other diseases such benign paroxysmal positional vertigo, labyrinthitis and vestibular neuronitis, drug poisoning, sudden deafness, vertigo, vertebrobasilar insufficiency and intracranial lesions.;Inclusion criteria: 1. Episodes of paroxysmal vertigo 2 or more times, lasting 20 min to 2 hours each time. Dysfunction of autonomic nervous system and balance disorders. Unconscious loss; 2. The most frequent hearing loss is low frequency hearing loss, and the hearing loss is gradually aggravated with the progression of the disease. At least 1 pure tone audiometry is sensorineural hearing loss, and the phenomenon of auditory recruitment can occur; 3. Associated with tinnitus and (or) ear fullness; 4. Exclusion of other diseases such benign paroxysmal positional vertigo, labyrinthitis and vestibular neuronitis, drug poisoning, sudden deafness, vertigo, vertebrobasilar insufficiency and intracranial lesions.;Inclusion criteria: 1. Episodes of paroxysmal vertigo 2 or more times, lasting 20 min to 2 hours each time. Dysfunction of autonomic nervous system and balance disorders. Unconscious loss; 2. The most frequent hearing loss is low frequency hearing loss, and the hearing loss is gradually aggravated with the progression of the disease. At least 1 pure tone audiometry is sensorineural hearing loss, and the phenomenon of auditory recruitment can occur; 3. Associated with tinnitus and (or) ear fullness; 4. Exclusion of other diseases such benign paroxysmal positional vertigo, labyrinthitis and vestibular neuronitis, drug poisoning, sudden deafness, vertigo, vertebrobasilar insufficiency and intracranial lesions.

Exclusion criteria

Exclusion criteria: Exclusion of other diseases such benign paroxysmal positional vertigo, labyrinthitis and vestibular neuronitis, drug poisoning, sudden deafness, vertigo, vertebrobasilar insufficiency and intracranial lesions.;Exclusion criteria: Exclusion of other diseases such benign paroxysmal positional vertigo, labyrinthitis and vestibular neuronitis, drug poisoning, sudden deafness, vertigo, vertebrobasilar insufficiency and intracranial lesions.;Exclusion criteria: Exclusion of other diseases such benign paroxysmal positional vertigo, labyrinthitis and vestibular neuronitis, drug poisoning, sudden deafness, vertigo, vertebrobasilar insufficiency and intracranial lesions.;Exclusion criteria: Exclusion of other diseases such benign paroxysmal positional vertigo, labyrinthitis and vestibular neuronitis, drug poisoning, sudden deafness, vertigo, vertebrobasilar insufficiency and intracranial lesions.;Exclusion criteria: Exclusion of other diseases such benign paroxysmal positional vertigo, labyrinthitis and vestibular neuronitis, drug poisoning, sudden deafness, vertigo, vertebrobasilar insufficiency and intracranial lesions.

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy rate;

Countries

China

Contacts

Public ContactHongbo Zhang;Hongbo Zhang;Hongbo Zhang;Hongbo Zhang;Hongbo Zhang ;;;;

Third People's Hospital of Huzhou, Zhejiang Province, China;Third People's Hospital of Huzhou, Zhejiang Province, China;Third People's Hospital of Huzhou, Zhejiang Province, China;Third People's Hospital of Huzhou, Zhejiang Province, China;Third People's Hospital of Huzhou, Zhejiang Province, China

zhb005005@163.com;zhb005005@163.com;zhb005005@163.com;zhb005005@163.com;zhb005005@163.com+86 13819226077;+86 13819226077;+86 13819226077;+86 13819226077;+86 13819226077

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026